TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,078,781 | -0.5% | 134,375 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $2,089,776 | -11.4% | 133,022 | -7.1% | 0.00% | 0.0% |
| Q1 2023 | $2,358,535 | +105996.9% | 143,115 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $2,223 | -99.9% | 142,499 | +7.4% | 0.00% | 0.0% |
| Q3 2022 | $1,720,000 | +0.5% | 132,632 | +8.8% | 0.00% | 0.0% |
| Q2 2022 | $1,712,000 | +12.0% | 121,919 | +14.2% | 0.00% | – |
| Q1 2022 | $1,529,000 | -4.5% | 106,762 | -9.1% | 0.00% | – |
| Q4 2021 | $1,601,000 | +14.3% | 117,449 | +37.3% | 0.00% | – |
| Q3 2021 | $1,401,000 | -2.6% | 85,529 | 0.0% | 0.00% | – |
| Q2 2021 | $1,439,000 | -13.0% | 85,529 | -5.6% | 0.00% | -100.0% |
| Q1 2021 | $1,654,000 | +0.3% | 90,589 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,649,000 | +41.1% | 90,589 | +38.3% | 0.00% | – |
| Q3 2020 | $1,169,000 | -51.5% | 65,504 | -51.2% | 0.00% | -100.0% |
| Q2 2020 | $2,409,000 | -37.5% | 134,365 | -47.1% | 0.00% | -50.0% |
| Q1 2020 | $3,856,000 | -34.4% | 254,012 | -14.7% | 0.00% | 0.0% |
| Q4 2019 | $5,876,000 | -50.1% | 297,801 | -56.5% | 0.00% | -60.0% |
| Q3 2019 | $11,773,000 | -17.3% | 684,487 | -14.9% | 0.01% | -16.7% |
| Q2 2019 | $14,232,000 | -45.2% | 804,046 | -36.6% | 0.01% | -40.0% |
| Q1 2019 | $25,956,000 | – | 1,268,867 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |